GILROSE PHARMACEUTICALS LLC has a total of 18 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and agriculture are WANG HONGKUI, MARVAL BIOSCIENCES INC and DONGGUAN MATHEMATICAL ENGINEERING ACADEMY OF CHINESE MEDICINE GUANGZHOU UNIVERSITY OF CHINESE MEDICI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Diagnosis and surgery | |
#3 | Therapeutic chemical compounds | |
#4 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Roseman Bruce | 17 |
#2 | Kaplan Gilla | 17 |
#3 | Gilla Kaplan | 1 |
#4 | Bruce Roseman | 1 |
Publication | Filing date | Title |
---|---|---|
US2017251628A1 | Pre-frontal cortex processing disorder speech, gait and limb impairments treatment | |
CN108025003A | Prefrontal cortex handles illness, gait and physical handicaps treatment | |
US2016199366A1 | Pre-frontal cortex processing disorder gait and limb impairments treatment | |
US2016113916A1 | Pharmaceutical intervention for treating an apraxia of speech in children | |
US2015283122A1 | Pharmaceutical intervention and method for treating an apraxia of speech in children | |
US2014357667A1 | Treatment of cerebral palsy impaired speech in children |